Report cover image

Global Botanical Drug Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 191 Pages
SKU # APRC20359527

Description

Summary

According to APO Research, the global Botanical Drug market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Botanical Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.

The Asia-Pacific market for Botanical Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Botanical Drug market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.

The Europe market for Botanical Drug is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Botanical Drug market include Yunnan Baiyao, Tong Ren Tang, Buchang Pharmaceuticals, Guangzhou Baiyunshan Pharmaceutical, Weleda, Tsumura, Tasly Holding Group, Taiji and Schwabe, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.

This report presents an overview of global market for Botanical Drug, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Botanical Drug, also provides the value of main regions and countries. Of the upcoming market potential for Botanical Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Botanical Drug revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Botanical Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Botanical Drug company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Botanical Drug Segment by Company

Yunnan Baiyao
Tong Ren Tang
Buchang Pharmaceuticals
Guangzhou Baiyunshan Pharmaceutical
Weleda
Tsumura
Tasly Holding Group
Taiji
Schwabe
Kwangdong
Jumpcan Pharmaceutical
Huarun 999
GW Pharmaceuticals
China TCM
Bionorica Se
Botanical Drug Segment by Type

Prescription Drug
OTC
Botanical Drug Segment by Application

Tumor
Cardiovascular
Respiratory System
Other
Botanical Drug Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Botanical Drug status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Botanical Drug key companies, revenue, market share, and recent developments.
3. To split the Botanical Drug breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Botanical Drug market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Botanical Drug significant trends, drivers, influence factors in global and regions.
6. To analyze Botanical Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Botanical Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Botanical Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Botanical Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Botanical Drug industry.
Chapter 3: Detailed analysis of Botanical Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Botanical Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Botanical Drug in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.

Table of Contents

191 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Botanical Drug Market Size, 2020 VS 2024 VS 2031
1.3 Global Botanical Drug Market Size (2020-2031)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Botanical Drug Market Dynamics
2.1 Botanical Drug Industry Trends
2.2 Botanical Drug Industry Drivers
2.3 Botanical Drug Industry Opportunities and Challenges
2.4 Botanical Drug Industry Restraints
3 Botanical Drug Market by Company
3.1 Global Botanical Drug Company Revenue Ranking in 2024
3.2 Global Botanical Drug Revenue by Company (2020-2025)
3.3 Global Botanical Drug Company Ranking (2023-2025)
3.4 Global Botanical Drug Company Manufacturing Base and Headquarters
3.5 Global Botanical Drug Company Product Type and Application
3.6 Global Botanical Drug Company Establishment Date
3.7 Market Competitive Analysis
3.7.1 Global Botanical Drug Market Concentration Ratio (CR5 and HHI)
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.7.3 2024 Botanical Drug Tier 1, Tier 2, and Tier 3 Companies
3.8 Mergers and Acquisitions Expansion
4 Botanical Drug Market by Type
4.1 Botanical Drug Type Introduction
4.1.1 Prescription Drug
4.1.2 OTC
4.2 Global Botanical Drug Sales Value by Type
4.2.1 Global Botanical Drug Sales Value by Type (2020 VS 2024 VS 2031)
4.2.2 Global Botanical Drug Sales Value by Type (2020-2031)
4.2.3 Global Botanical Drug Sales Value Share by Type (2020-2031)
5 Botanical Drug Market by Application
5.1 Botanical Drug Application Introduction
5.1.1 Tumor
5.1.2 Cardiovascular
5.1.3 Respiratory System
5.1.4 Other
5.2 Global Botanical Drug Sales Value by Application
5.2.1 Global Botanical Drug Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global Botanical Drug Sales Value by Application (2020-2031)
5.2.3 Global Botanical Drug Sales Value Share by Application (2020-2031)
6 Botanical Drug Regional Value Analysis
6.1 Global Botanical Drug Sales Value by Region: 2020 VS 2024 VS 2031
6.2 Global Botanical Drug Sales Value by Region (2020-2031)
6.2.1 Global Botanical Drug Sales Value by Region: 2020-2025
6.2.2 Global Botanical Drug Sales Value by Region (2026-2031)
6.3 North America
6.3.1 North America Botanical Drug Sales Value (2020-2031)
6.3.2 North America Botanical Drug Sales Value Share by Country, 2024 VS 2031
6.4 Europe
6.4.1 Europe Botanical Drug Sales Value (2020-2031)
6.4.2 Europe Botanical Drug Sales Value Share by Country, 2024 VS 2031
6.5 Asia-Pacific
6.5.1 Asia-Pacific Botanical Drug Sales Value (2020-2031)
6.5.2 Asia-Pacific Botanical Drug Sales Value Share by Country, 2024 VS 2031
6.6 South America
6.6.1 South America Botanical Drug Sales Value (2020-2031)
6.6.2 South America Botanical Drug Sales Value Share by Country, 2024 VS 2031
6.7 Middle East & Africa
6.7.1 Middle East & Africa Botanical Drug Sales Value (2020-2031)
6.7.2 Middle East & Africa Botanical Drug Sales Value Share by Country, 2024 VS 2031
7 Botanical Drug Country-level Value Analysis
7.1 Global Botanical Drug Sales Value by Country: 2020 VS 2024 VS 2031
7.2 Global Botanical Drug Sales Value by Country (2020-2031)
7.2.1 Global Botanical Drug Sales Value by Country (2020-2025)
7.2.2 Global Botanical Drug Sales Value by Country (2026-2031)
7.3 USA
7.3.1 USA Botanical Drug Sales Value Growth Rate (2020-2031)
7.3.2 USA Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.3.3 USA Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.4 Canada
7.4.1 Canada Botanical Drug Sales Value Growth Rate (2020-2031)
7.4.2 Canada Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.4.3 Canada Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.5 Mexico
7.5.1 Mexico Botanical Drug Sales Value Growth Rate (2020-2031)
7.5.2 Mexico Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.5.3 Mexico Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.6 Germany
7.6.1 Germany Botanical Drug Sales Value Growth Rate (2020-2031)
7.6.2 Germany Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.6.3 Germany Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.7 France
7.7.1 France Botanical Drug Sales Value Growth Rate (2020-2031)
7.7.2 France Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.7.3 France Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.8 U.K.
7.8.1 U.K. Botanical Drug Sales Value Growth Rate (2020-2031)
7.8.2 U.K. Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.8.3 U.K. Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.9 Italy
7.9.1 Italy Botanical Drug Sales Value Growth Rate (2020-2031)
7.9.2 Italy Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.9.3 Italy Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.10 Spain
7.10.1 Spain Botanical Drug Sales Value Growth Rate (2020-2031)
7.10.2 Spain Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.10.3 Spain Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.11 Russia
7.11.1 Russia Botanical Drug Sales Value Growth Rate (2020-2031)
7.11.2 Russia Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.11.3 Russia Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.12 Netherlands
7.12.1 Netherlands Botanical Drug Sales Value Growth Rate (2020-2031)
7.12.2 Netherlands Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.12.3 Netherlands Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.13 Nordic Countries
7.13.1 Nordic Countries Botanical Drug Sales Value Growth Rate (2020-2031)
7.13.2 Nordic Countries Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.13.3 Nordic Countries Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.14 China
7.14.1 China Botanical Drug Sales Value Growth Rate (2020-2031)
7.14.2 China Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.14.3 China Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.15 Japan
7.15.1 Japan Botanical Drug Sales Value Growth Rate (2020-2031)
7.15.2 Japan Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.15.3 Japan Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.16 South Korea
7.16.1 South Korea Botanical Drug Sales Value Growth Rate (2020-2031)
7.16.2 South Korea Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.16.3 South Korea Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.17 India
7.17.1 India Botanical Drug Sales Value Growth Rate (2020-2031)
7.17.2 India Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.17.3 India Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.18 Australia
7.18.1 Australia Botanical Drug Sales Value Growth Rate (2020-2031)
7.18.2 Australia Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.18.3 Australia Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.19 Southeast Asia
7.19.1 Southeast Asia Botanical Drug Sales Value Growth Rate (2020-2031)
7.19.2 Southeast Asia Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.19.3 Southeast Asia Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.20 Brazil
7.20.1 Brazil Botanical Drug Sales Value Growth Rate (2020-2031)
7.20.2 Brazil Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.20.3 Brazil Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.21 Argentina
7.21.1 Argentina Botanical Drug Sales Value Growth Rate (2020-2031)
7.21.2 Argentina Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.21.3 Argentina Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.22 Chile
7.22.1 Chile Botanical Drug Sales Value Growth Rate (2020-2031)
7.22.2 Chile Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.22.3 Chile Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.23 Colombia
7.23.1 Colombia Botanical Drug Sales Value Growth Rate (2020-2031)
7.23.2 Colombia Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.23.3 Colombia Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.24 Peru
7.24.1 Peru Botanical Drug Sales Value Growth Rate (2020-2031)
7.24.2 Peru Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.24.3 Peru Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.25 Saudi Arabia
7.25.1 Saudi Arabia Botanical Drug Sales Value Growth Rate (2020-2031)
7.25.2 Saudi Arabia Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.25.3 Saudi Arabia Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.26 Israel
7.26.1 Israel Botanical Drug Sales Value Growth Rate (2020-2031)
7.26.2 Israel Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.26.3 Israel Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.27 UAE
7.27.1 UAE Botanical Drug Sales Value Growth Rate (2020-2031)
7.27.2 UAE Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.27.3 UAE Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.28 Turkey
7.28.1 Turkey Botanical Drug Sales Value Growth Rate (2020-2031)
7.28.2 Turkey Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.28.3 Turkey Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.29 Iran
7.29.1 Iran Botanical Drug Sales Value Growth Rate (2020-2031)
7.29.2 Iran Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.29.3 Iran Botanical Drug Sales Value Share by Application, 2024 VS 2031
7.30 Egypt
7.30.1 Egypt Botanical Drug Sales Value Growth Rate (2020-2031)
7.30.2 Egypt Botanical Drug Sales Value Share by Type, 2024 VS 2031
7.30.3 Egypt Botanical Drug Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Yunnan Baiyao
8.1.1 Yunnan Baiyao Comapny Information
8.1.2 Yunnan Baiyao Business Overview
8.1.3 Yunnan Baiyao Botanical Drug Revenue and Gross Margin (2020-2025)
8.1.4 Yunnan Baiyao Botanical Drug Product Portfolio
8.1.5 Yunnan Baiyao Recent Developments
8.2 Tong Ren Tang
8.2.1 Tong Ren Tang Comapny Information
8.2.2 Tong Ren Tang Business Overview
8.2.3 Tong Ren Tang Botanical Drug Revenue and Gross Margin (2020-2025)
8.2.4 Tong Ren Tang Botanical Drug Product Portfolio
8.2.5 Tong Ren Tang Recent Developments
8.3 Buchang Pharmaceuticals
8.3.1 Buchang Pharmaceuticals Comapny Information
8.3.2 Buchang Pharmaceuticals Business Overview
8.3.3 Buchang Pharmaceuticals Botanical Drug Revenue and Gross Margin (2020-2025)
8.3.4 Buchang Pharmaceuticals Botanical Drug Product Portfolio
8.3.5 Buchang Pharmaceuticals Recent Developments
8.4 Guangzhou Baiyunshan Pharmaceutical
8.4.1 Guangzhou Baiyunshan Pharmaceutical Comapny Information
8.4.2 Guangzhou Baiyunshan Pharmaceutical Business Overview
8.4.3 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Revenue and Gross Margin (2020-2025)
8.4.4 Guangzhou Baiyunshan Pharmaceutical Botanical Drug Product Portfolio
8.4.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments
8.5 Weleda
8.5.1 Weleda Comapny Information
8.5.2 Weleda Business Overview
8.5.3 Weleda Botanical Drug Revenue and Gross Margin (2020-2025)
8.5.4 Weleda Botanical Drug Product Portfolio
8.5.5 Weleda Recent Developments
8.6 Tsumura
8.6.1 Tsumura Comapny Information
8.6.2 Tsumura Business Overview
8.6.3 Tsumura Botanical Drug Revenue and Gross Margin (2020-2025)
8.6.4 Tsumura Botanical Drug Product Portfolio
8.6.5 Tsumura Recent Developments
8.7 Tasly Holding Group
8.7.1 Tasly Holding Group Comapny Information
8.7.2 Tasly Holding Group Business Overview
8.7.3 Tasly Holding Group Botanical Drug Revenue and Gross Margin (2020-2025)
8.7.4 Tasly Holding Group Botanical Drug Product Portfolio
8.7.5 Tasly Holding Group Recent Developments
8.8 Taiji
8.8.1 Taiji Comapny Information
8.8.2 Taiji Business Overview
8.8.3 Taiji Botanical Drug Revenue and Gross Margin (2020-2025)
8.8.4 Taiji Botanical Drug Product Portfolio
8.8.5 Taiji Recent Developments
8.9 Schwabe
8.9.1 Schwabe Comapny Information
8.9.2 Schwabe Business Overview
8.9.3 Schwabe Botanical Drug Revenue and Gross Margin (2020-2025)
8.9.4 Schwabe Botanical Drug Product Portfolio
8.9.5 Schwabe Recent Developments
8.10 Kwangdong
8.10.1 Kwangdong Comapny Information
8.10.2 Kwangdong Business Overview
8.10.3 Kwangdong Botanical Drug Revenue and Gross Margin (2020-2025)
8.10.4 Kwangdong Botanical Drug Product Portfolio
8.10.5 Kwangdong Recent Developments
8.11 Jumpcan Pharmaceutical
8.11.1 Jumpcan Pharmaceutical Comapny Information
8.11.2 Jumpcan Pharmaceutical Business Overview
8.11.3 Jumpcan Pharmaceutical Botanical Drug Revenue and Gross Margin (2020-2025)
8.11.4 Jumpcan Pharmaceutical Botanical Drug Product Portfolio
8.11.5 Jumpcan Pharmaceutical Recent Developments
8.12 Huarun 999
8.12.1 Huarun 999 Comapny Information
8.12.2 Huarun 999 Business Overview
8.12.3 Huarun 999 Botanical Drug Revenue and Gross Margin (2020-2025)
8.12.4 Huarun 999 Botanical Drug Product Portfolio
8.12.5 Huarun 999 Recent Developments
8.13 GW Pharmaceuticals
8.13.1 GW Pharmaceuticals Comapny Information
8.13.2 GW Pharmaceuticals Business Overview
8.13.3 GW Pharmaceuticals Botanical Drug Revenue and Gross Margin (2020-2025)
8.13.4 GW Pharmaceuticals Botanical Drug Product Portfolio
8.13.5 GW Pharmaceuticals Recent Developments
8.14 China TCM
8.14.1 China TCM Comapny Information
8.14.2 China TCM Business Overview
8.14.3 China TCM Botanical Drug Revenue and Gross Margin (2020-2025)
8.14.4 China TCM Botanical Drug Product Portfolio
8.14.5 China TCM Recent Developments
8.15 Bionorica Se
8.15.1 Bionorica Se Comapny Information
8.15.2 Bionorica Se Business Overview
8.15.3 Bionorica Se Botanical Drug Revenue and Gross Margin (2020-2025)
8.15.4 Bionorica Se Botanical Drug Product Portfolio
8.15.5 Bionorica Se Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.